-
Infection and Drug Resistance
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Prevention strategies for antimicrobial resistance: a systematic review of the literature
Review
(3546) Views (1521) Full article downloads
Authors: Whitney P Caron, Shaker A Mousa
Published Date May 2010
Volume 2010:3 Pages 25 - 33
DOI: http://dx.doi.org/10.2147/IDR.S10018
Whitney P Caron1, Shaker A Mousa1,2
1The Pharmaceutical Research Institute, Center of Excellence of Infection Prevention (CEIP), Albany College of Pharmacy and Health Sciences, Albany, NY, USA; 2King Saud University, Riyadh, Saudi Arabia
Abstract: Antibiotics offer great benefits by reducing the duration and severity of illnesses and aiding in infection transmission control. With this being said, the inexorable process of antimicrobial drug resistance is to some degree unavoidable. Although drug resistance will likely persist and is to be expected, the overall level can be dramatically decreased with increased attention to antibiotic overuse and the pharmacokinetic and pharmacodynamic properties of different drug formulations, and the use of proper hygiene and protective barriers. Implementation of such practices as microbial surveillance and prophylaxis has been shown to result in decreased hospital length of stay, health care costs and mortality due to drug-resistant infections. This review will summarize current progress in preventative techniques aimed at reducing the incidence of infection by antimicrobial-resistant bacteria and the emergence and spread of antimicrobial-resistant strains. By employing a variety of prevention strategies, including proper personal hygiene, prescreening for carrier status before hospital admission, disinfection of hospital rooms, and careful monitoring of antimicrobial prescribing, marked progress can be achieved in the control of drug-resistant pathogens, which can translate into more effective antimicrobial therapy.
Keywords: infection prevention, antibiotic, personal hygiene, disinfection, microbial surveillance, drug-resistant pathogen
Other articles by Professor Shaker Mousa
Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
Pharmacogenomics in osteoporosis: Steps toward personalized medicine
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent
Readers of this article also read:
Anidulafungin and its role in candida infections
Occult hepatitis B virus infection in Egyptian hemodialysis patients with or without hepatitis C virus infection
Current strategies for the prevention and management of central line-associated bloodstream infections
Boceprevir in the treatment of chronic hepatitis C virus infection
Resistance to antimicrobial drugs in Ghana
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India
The effects of daily chlorhexidine bathing on cutaneous bacterial isolates: a pilot study
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
- Treatment of drug-resistant tuberculosis
- Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
- High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India




